Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Tdap Vaccine: Randomized Phase IIIb Trial in Healthy Participants 9–60 Years of Age in the Philippines

Incorporating dengue vaccination into existing childhood vaccination programs could increase vaccine coverage. This study assessed the safety and immunogenicity of concomitant versus sequential administration of the combined tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) va...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos, Jaime, Montellano, May Emmeline, Solante, Rontgene, Perreras, Nicole, Meyer, Stéphanie, Toh, Myew-Ling, Zocchetti, Céline, Vigne, Claire, Mascareñas, Cesar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Vaccine Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357045/
https://www.ncbi.nlm.nih.gov/pubmed/34117198
http://dx.doi.org/10.1097/INF.0000000000003220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357045/
https://www.ncbi.nlm.nih.gov/pubmed/34117198
http://dx.doi.org/10.1097/INF.0000000000003220

Ejemplares similares